Christopher Toombs
Direttore/Membro del Consiglio presso IKARIA, INC.
Posizioni attive di Christopher Toombs
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| IKARIA, INC. | Direttore/Membro del Consiglio | 01/03/2006 | - |
Faraday Pharmaceuticals, Inc.
 Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Direttore Tecnico/Scientifico/R&S | 01/01/2014 | - |
| Fondatore | 01/01/2014 | - | |
Proniras Corp.
 Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Fondatore | 01/01/2018 | - |
| Corporate Officer/Principal | 01/01/2018 | - | |
Accelerator Services Corp
 Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Investitore di Private Equity | - | - |
Storia della carriera di Christopher Toombs
Precedenti posizioni note di Christopher Toombs
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| MuciMed, Inc. | Investitore di Private Equity | 01/03/2014 | 30/06/2016 |
Formazione di Christopher Toombs
| Wheaton College Graduate School | Undergraduate Degree |
| Wake Forest School of Medicine | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 8 |
Posizioni
| Founder | 2 |
| Private Equity Investor | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 4 |
| Consumer Services | 3 |
| Finance | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 5 |
|---|---|
Faraday Pharmaceuticals, Inc.
Faraday Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Faraday Pharmaceuticals, Inc. engages in the research and development of elemental reducing agents (ERAs). Its therapeutic agents have potential applications for treatment of critical care illnesses. The company was founded by Mark B. Roth and Christopher Toombs in 2014 and is headquartered in Seattle, WA. | Health Technology |
Ikaria, Inc.
 Ikaria, Inc. BiotechnologyHealth Technology Ikaria, Inc. operates as a biotherapeutics company focused on developing and commercializing innovative therapeutics and interventions designed to meet the medical needs of critically ill patients. It offers INOMAX for inhalation, which is used to treat newborns suffering from hypoxic respiratory failure, and is making a major impact on the critical care environment. The company was founded on August 18, 2006 and is headquartered in Clinton, NJ. | Health Technology |
| MuciMed, Inc. | |
Proniras Corp.
Proniras Corp. BiotechnologyHealth Technology Proniras Corp. operates as a bio technology company. The company is headquartered in Seattle, WA. | Health Technology |
Accelerator Services Corp
Accelerator Services Corp Investment ManagersFinance Accelerator Services Corp (Accelerator Services) is a venture capital firm founded in 2003 by Carl Weissman and Rodney F. Burgar. The firm is headquartered in Seattle, Washington. | Finance |
- Borsa valori
- Insiders
- Christopher Toombs
- Esperienza
